Clinical trials
Terminated Phase 1 Endometrial Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
32 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2011 | 1 |
| 2014 | 1 |
| 2015 | 2 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 4 |
| 2020 | 4 |
| 2021 | 6 |
| 2022 | 5 |
| 2024 | 4 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 32 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pfizer | 3 |
| Seagen Inc. | 2 |
| AbbVie | 1 |
| Accent Therapeutics | 1 |
| ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) | 1 |
| Black Diamond Therapeutics, Inc. | 1 |
| Blueprint Medicines Corporation | 1 |
| Calando Pharmaceuticals | 1 |
| Dana-Farber Cancer Institute | 1 |
| Fate Therapeutics | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Endometrial Neoplasms | 32 |
| Ovarian Neoplasms | 19 |
| Stomach Neoplasms | 10 |
| Breast Neoplasms | 9 |
| Carcinoma, Non-Small-Cell Lung | 9 |
| Uterine Cervical Neoplasms | 9 |
| Triple Negative Breast Neoplasms | 8 |
| Carcinoma, Renal Cell | 6 |
| Lung Neoplasms | 6 |
| Fallopian Tube Neoplasms | 5 |
Trials
Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.